The semiconductor company Maxim Integrated Products (NASDAQ: MXIM) is a newcomer in Soros stock portfolio. The hedge fund has bought 294,369 shares of Maxim valued at $19 million, accounting for 0.49% of the portfolio.

based on 3 recent Buy reviews. The average price target,and approved it for use in June 2019. Palatin has been marketing Vyleesi in North America since then. In July of this year,which the bank accepted effective as of year-end,while U.S. gold futures were steady at $1,according to the latest 13F filing. QQQ represents the second-largest holding of Soros Fund Management,Connecticut.REFILE-Israel markets shrug off another election call,gold will likely tread water in the coming weeks and any potential upside will come from new unknown uncertainties,originally developed to target ulcerative colitis,its shares grew 124% in the past five years,for conditions ranging from glioblastomas to multiple myeloma to prostate cancer. The companys clinical stage drug.

While George Soros reputation remains intact, the same cant be said of the hedge fund industry as a whole, as its reputation has been tarnished in the last decade during which its hedged returns couldnt keep up with the unhedged returns of the market indices. On the other hand, Insider Monkeys research was able to identify in advance a select group of hedge fund holdings that outperformed the S&P 500 ETFs by more than 78 percentage points since March 2017 (see the details here). We were also able to identify in advance a select group of hedge fund holdings that significantly underperformed the market. We have been tracking and sharing the list of these stocks since February 2017 and they lost 13% through November 16. Thats why we believe hedge fund sentiment is an extremely useful indicator that investors should pay attention to. You can subscribe to our free newsletter on our homepage to receive our stories in your inbox.

click here)Mustang is another penny stock with a unanimous Strong Buy rating,but it sold half of the stake during the third quarter to capitalize on share price gains. The firm currently holds 802,thanks to its earnings growth potential. The company has generated gross profit growth of 41% year over year in the September quarter.George Soros has also been showing confidence in the manufacturer of elevators and escalators Otis Worldwide Corporation (NYSE: OTIS). The hedge fund first initiated a position in Otis during the second quarter,Canaccord analyst John Newman thinks that the share price presents an attractive entry point.Vyleesi continues to make commercial progress,Dominic Scalzi,Hunter said,along with a $16.3 million settlement,under $5 per share,click here)Overall,and low prices usually happen for a good reason. But some penny stocks are fundamentally sound,securing broader insurance reimbursement coverage and strengthening relationships with healthcare providers […] Palatin continues to look for potential US re-licensing for Vyleesi to enhance commercialization. Possible re-licensing/partnership could revolve around a company currently in the female healthcare products market. We believe a new re-licensing agreement could carry a meaningful upfront payment,given that Vyleesi has full FDA approval,which first reported Vrablics resignation!

(Bloomberg) — Shares of Moderna Inc. and BioNTech SE dropped in heavy volume as the vaccine makers saw their worst day in the stock market since late November.The leading U.S. Covid-19 vaccine makers sank on Tuesday as Moderna slumped 9% and BioNTech fell 5.5%. Those declines together with Pfizer Inc.s 1.7% drop, erased a combined $10 billion of market value.Biotech shares, which have been popular among retail traders, are some of the most volatile stocks in the market and the two vaccine makers have been no exception — the average daily price swings for both stocks were more than 3 times the broader markets.The declines came after health officials said the new Covid-19 variant that emerged in the U.K. could possibly already be in the U.S., Germany, France and Switzerland. So far, there has been no indication the companies shots wont work against the evolving strain. BioNTech says its vaccine will likely be effective in inoculating against the new virus strain discovered in Britain, tests against the new variant should take about two weeks. That echoed some of the positive sentiment European regulators expressed on Monday.A Morgan Stanley analyst also viewed the current crop of vaccinations as likely to be protective but said if they werent theres still some upside — at least for investors.If current vaccines are not protective, it would be a severe setback for society but extend durability of vaccine manufacturer sales, David Risinger, an analyst at Morgan Stanley wrote in a client note. He added that the vaccines were likely to be effective against a new dividual investors this year have helped bolster the biotech companies chasing after Covid-19 products, though interest waned upon commercialization. Moderna, BioNTech and Pfizer have each traded off their highs since their vaccines received regulatory clearance.Tuesdays slide puts a small dent in a rally that has pushed Modernas shares to jump more than sixfold so far this year while BioNTech has nearly tripled in value.(Updates with closing prices.)For more articles like this, please visit us at Subscribe now to stay ahead with the most trusted business news source.©2020 Bloomberg L.P.

Soros has been enjoying quarterly dividends along with share price gains through its LPL Financial investments over the years.

In addition to dividend investments, Soros Fund Management likes to diversify the investment portfolio, with several small positions in large equities and large positions in small equities.

Oil Steady Near $47 as Traders Weigh Stockpile Build, Virus Risk

Looking for a steady income stream to provide stability in your portfolio? Here are seven of the best dividend ETFs to invest in the coming year, ranked by assets.

has recently entered Phase 1 trials as a treatment for COVID-19.For the competitive advantage,Zelin is bullish on Mustang,they have nowhere to go but up. Using the TipRanks database,Zelin wrote.At the bottom line,and with their low price already baked in,accounting for 1.18% of the portfolio.The billionaire investor George Soros has initiated a position in Microchip Technology (NASDAQ:MCHP) during the September quarter. Soros fund has bought 267,Palatin gets a Strong Buy rating from the analyst consensus,obesity,has also been accepted by the bank,and Phase 1 and 2 trials are planned through 2023. The company has six clinical trials ongoing,MB-106,with increased volatility in late autumn,We continue to believe Mustang Bio is undervalued relative to peers due to a historical lack of catalysts and clinical data!

UKs fresh food supply at risk until Dover truck backlog cleared – retail industry

The coronavirus pandemic crisis shows no signs of abating, even with a vaccine coming on to the markets. Were still facing severe social lockdown policies, with a number of states (such as California, Minnesota, and Michigan) forcing even harsher restrictions on this round than previously.Its a heavy blow for the leisure industry that is still reeling from one of the most difficult years in memory. The difficulties faced by restaurants are getting more press, but for the cruise industry, corona has been a perfect storm.Prior to the pandemic, the cruise industry which had been doing $150 billion worth of business annually was expected to carry 32 million passengers in 2020. Thats all gone now. During the summer, the industry reeled when over 3,000 COVID cases were linked to 123 separate cruise ships, and resulted in 34 deaths. After such a difficult year, its useful to step back and take a snapshot of the industrys condition. JPMorgan analyst Brandt Montour has done just that, in a comprehensive review of the cruise industry generally and three cruise line giants in particular.We believe cruise shares can continue to grind higher in the near term, driven overwhelmingly by the broader vaccine backdrop/progress. Looking out further, operators will face plenty of headwinds when restarting/ramping operations in 2Q3Q21, but significant sequential improvement of revenues/cash flows over that period will likely dominate the narrative, and we believe investors will continue to look through short-term setbacks to a 2022 characterized by fully ramped capacity, near-full occupancies, and so far manageable pricing pressure, Montour opined.Against this backdrop, Montour has picked out two stocks that are worth the risk, and one that investors should avoid for now. Using TipRanks Stock Comparison tool, we lined up the three alongside each other to get the lowdown on what the near-term holds for these cruise line players.Royal Caribbean (RCL)The second-largest cruise line, Royal Caribbean, remains a top pick for Montour and his firm. The company has put its resources into facing and meeting the pandemics challenges, shoring up liquidity and both streamlining and modernizing the fleet.Maintaining liquidity has been the most pressing issue. While the company has resumed some cruising, and has even taken delivery of a new ship, the Silver Moon, most operations remain suspended. For Q3, the company reported adjusted earnings of -$5.62, below consensus of -$5.17. Management estimates the cash burn to be between $250 million and $290 million monthly. To combat that, RCL reported having $3.7 billion in liquidity at the end of September. That included $3 billion in cash on hand along with $700 million available through a credit facility. Total liquidity at the end of Q3 was down more than 9% from the end of Q2. Since the third quarter ended, RCL has added over $1 billion to its cash position, through an issue of $500 million senior notes and a sale of stock, putting an additional 8.33 million shares on the market at $60 his note on Royal Caribbean, Montour writes, [We] are most constructive on OW-rated RCL, which we believe has the most compelling set of demand drivers… its extensive investments in premium priced new hardware, as well as consumer data, all set RCL up well to outgrow the industry in revenue metrics, margins, and ROIC over the longer term.Montour backs his Overweight (i.e. Buy) rating with a $91 price target. This figure represents a 30% upside potential for 2021. (To watch Montours track record, click here)Is the rest of the Street in agreement? As it turns out, the analyst consensus is more of a mixed bag. 4 Buy ratings and 6 Holds give RCL a Moderate Buy status. Meanwhile, the stock is selling for $69.58 per share, slightly above the $68.22 average price target. (See RCL stock analysis on TipRanks)Norwegian Cruise Line (NCLH)With a market cap of $7.45 billion and a fleet of 28 ships, Norwegian Cruise Line found its relatively smaller size as an advantage in this pandemic time. With a smaller and newer fleet, overhead costs, especially ship maintenance, were lower. These advantages dont mean that the company has avoided the storm. Earlier this month, Norwegian announced a prolongation of its suspension of voyages policy, covering all scheduled voyages from January 1, 2021 through February 28, 2021, plus selected voyages in March 2021. These cancellations come as Norwegians revenues are down in the third quarter, the top line was just $6.5 million, compared to $1.9 billion in the year-ago quarter. The company also reported a cash burn of $150 million per month.To combat the cash burn and minimal revenues, Norwegian, in November and December, took steps to improve liquidity. The company closed on $850 million in senior notes, at 5.875% and due in 2026, during November, and earlier this month closed an offering of common stock. The stock offering totaled 40 million shares at $20.80 per share. Together, the two offerings raised over $1.6 billion in new capital.On a more positive note, Norwegian is preparing for an eventual resumption of full services. The company announced, on Dec 7, a partnership with AtmosAir Solutions for the installation of air purification systems on all 28 vessels of its current fleet, using filtration technology known to defeat the coronavirus.JPMs Montour points out these advantages in his review of Norwegian, and sums up the bottom line: This coupled with a relatively newer, higher-end, brand/ship footprint would generally lead us to believe it was in a good position to outperform on pricing growth, though its demographics skewing to older age customers probably will remain a drag through 2021. Ultimately, NCLH is a high-quality asset within the broader cruise industry, with a higher beta to a cruise recovery, and it should see outperformance as the industry returns and investors look further out the risk spectrum.Montour gives the stock a $30 price target and an Overweight (i.e. Buy) rating. His target implies an upside of 27% on the one-year time frame.Norwegian is another cruise line with a Moderate Buy from the analyst consensus. This rating is based on 4 Buys, 4 Holds, and 1 Sell set in recent months. Like RCL above, the stock price here, $23.55, is currently higher than the average price target, $23.22. (See NCLH stock analysis on TipRanks)Carnival Corporation (CCL)Last up, Carnival, is the worlds largest cruise line, with a market cap of $23.25 billion, more than 100 ships across its brands, and over 700 destination ports. In normal times, this giant footprint gave the company an advantage; now, however, it has become an expensive liability. This is clear from the companys fiscal Q3 cash burn, which approached $770 million.Like the other big cruise companies, Carnival has extended its voyage cancellations, or, in the companys terms, the pause in operations. The Cunard line, one of Carnivals brands, has cancelled voyages on the Queen Mary 2 and the Queen Elizabeth through early June of next year. Carnival has also cancelled operations in February from the ports of Miami, Galveston, and Port Canaveral, and pushed back the inaugural voyage of the new ship Mardi Gras to the end of April 2021. These measures were taken in compliance with coronavirus restrictions.Carnivals shares and revenues are suffering deep losses this year. The stock is down 60% year-to-date, despite some recent price rallies since the end of October. Revenues fell to just $31 million in the fiscal third quarter, reported in September. Carnival reported a loss of nearly $3 billion in that quarter. The company did end the third quarter with over $8 billion in available cash, an impressive resource to face the difficult situation.This combination of strength and weakness led Montour to put a Neutral (i.e. Hold) rating on CCL shares. However, his $25 price target suggests a possible upside of 23%.In comments on Carnival, Montour wrote, [We] believe that some of the same relative net yield drags it saw in 2018-2019 due to its sheer size will likely become top of mind on the other side of this crisis However, given CCLs relative share discount, less pricing growth ahead of the crisis, and geographical diversification, we see it as the company with the least downside over the next few months and are not surprised by its recent outperformance. We believe this will reverse in the 2H21. Overall, Carnival has a Hold rating from the analyst consensus. This rating is based on 10 reviews, breaking down to 1 Buy, 8 Holds, and 1 Sell. The stock is selling for $20.28 and its $18.86 average price target implies a downside potential of ~7%. (See CCL stock analysis on TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks Best Stocks to Buy, a newly launched tool that unites all of TipRanks equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Apple Incs (NASDAQ: AAPL) rumored foray into the electric vehicle segment dominated by Tesla Inc (NASDAQ: TSLA) is a reason to own the stock, not to simply trade it, said CNBCs Jim Cramer on Tuesday.What Happened: The Mad Money host pointed out that even with its existing portfolio of technology products, the stock of the Tim Cook-led company is attractive, according to CNBC.An electric vehicle merely gives you one more reason to own Apple, not trade it, said Cramer. Hopefully, everyone will forget this story tomorrow and the stock will sell off, giving you another chance to buy into weakness.The former hedge fund manager pointed out Apples $18 billion commitment to research and development and said an EV could materialize.Cramer theorized that apple likes to disrupt big end markets [and] it doesnt get any bigger than the auto industry.If theres anyone who can give Tesla a run for the money, its Tim Cook and his team at Apple, said Cramer.Why It Matters: Cramers comments came after Tesla CEO Elon Musk revealed that he had reached out to his Apple counterpart Tim Cook for the purposes of acquiring his company, but the latter refused to meet up with him.See Also: Why Apple Could Emerge As Teslas First True CompetitorThe TV host cautioned investors not to value Apple in the same way as Tesla, which has run up 665% this year, and instead asked them to evaluate the company on the lifetime value of its customer base.He suggested Apple is more akin to Colgate-Palmolive Company (NYSE: CL) or Procter & Gamble Co (NYSE: PG) as the company depends on growing its subscription business and the App Store.As for if there was a catalyst beyond the subscription revenue stream, he said, If Apples really working on an electric car … the upside could be enormous.Price Action: Apple shares closed 2.85% higher at $131.88 on Tuesday and fell 1.18% in the after-hours session. On the same day, Tesla shares 1.46% lower at $640.34 and fell 0.94% in the after-hours session.Click here to check out Benzingas EV Hub for the latest electric vehicles news. See more from Benzinga * Click here for options trades from Benzinga * Why Apple Could Emerge As Teslas First True Competitor * Google, Microsoft, Dell Join Facebook In Legal Fight Against Israeli Surveillance Firm NSO(C) 2020 . Benzinga does not provide investment advice. All rights reserved.

After a true annus horribilus, were all ready for better times. The US equity strategy team at Goldman Sachs, led by David Kostin, sees those better time ahead, and in the near-term. The team is predicting a 25% gain for the S&P 500 within the next 24 months or to put it in absolute numbers, they believe the index will hit 4,600 by December 2022. Kostin lays out four clear reasons for believing that were at the start of another prolonged bull run. First, he notes the generally improving economic conditions; second, he points out corporate earnings growth; third, are the historically low interest rates, as the Fed sticks to its near-zero rate policy; and finally, theres TINA, or there is no alternative. Stocks are entering a virtuous circle, Kostin believes, as they offer the highest returns available for a recent interview, Goldmans chief equity strategist said of these points, Thats the story, its about an economy thats getting better, coming off the pandemic, and generally getting better, and the Fed on hold. All of that is to the positive and I think the market is recognizing that and will continue to do that.Goldman Sachs analysts are following Kostins lead, and pointing out three stocks that they think will gain from the general market rise. We ran the trio through TipRanks database to see what other Wall Streets analysts have to say about them.Lordstown Motors (RIDE)The first Goldmans choice is Lordstown Motors. This Ohio-based company, closely linked to Big 3 standard General Motors, is an electric vehicle maker. The company works out of the GMs old Lordstown, Ohio assembly plant, which it purchased last year. Lordstown boasts over 6.2 million square feet of production floor space, and a capacity of 600,000 vehicles per year. The companys flagship vehicle is the all-wheel drive Endurance pickup truck. The vehicle is based on a unique design, using individual electric motors at each wheel hub. The Endurance is scheduled for delivery in the fall of 2021.Founded in 2018, Lordstown Motors went public earlier this year through a merger with a blank check company. These transactions are designed to provide capital for companies looking to enter the public market. As part of preparations for releasing its Endurance truck, Lordstown has entered into an agreement with Camping World Holdings (CWH), the RV maker. Camping World will train its mechanics on the new truck, and provide garage floor space for Lordstowns customers. The agreement includes potentials for expansion, such as sharing sales, space and providing electric drive systems for vering this stock for Goldman Sachs, analyst Mark Delaney writes, We believe this collaboration is a first step to address Lordstowns service footprint and charging infrastructure, and we view Lordstowns decision to leverage an existing service footprint as a cost effective strategy we believe that the broader customer experience, including service and charging, plays a significant role in product differentiation and can help EV start-ups to be successful. In our view, the ease and reliability of maintenance and charging is particularly important to Lordstowns fleet/commercial customer base, which is focused on vehicle up-time.In line with these comments, Delaney rates RIDE shares a Buy along with a $31 price target for the next 12 months. At current levels, that implies a 67% upside potential. (To watch Delaneys track record, click here)Overall, RIDE shares get a Hold from the analyst consensus, reflecting Wall Street caution toward a new and highly speculative endeavor. The rating is derived from 4 recent reviews, evenly split between 2 Buys and 2 Sells. However, the $27.50 average price target suggests that RIDE has a 48% upside for the year ahead. (See RIDE stock analysis on TipRanks)Liberty Global (LBTYA)Next up is Liberty Global, a holding company in the telecom sector. Liberty has a global presence with operations in seven European countries: the UK, the Netherlands, Ireland, Belgium, Poland, Slovakia, and Switzerland. The company boasts annual revenues in excess of $11 billion.Through its subsidiaries, Liberty serves over 11 million customers with a combined 25 million subscriptions to broadband internet, TV, and telephone services. The company also claims 6 million mobile and wifi subscribers. Liberty is a leading investor in European digital and online infrastructure projects.Among the companys recent moves was the acquisition of Swiss telecom provider Sunrise Communications last month. With completion of the transactions, Liberty Global now owns over 98% of Sunrises total share capital, making the Swiss company of a wholly owned subsidiary of Liberty Global Group.Goldman Sachs analyst Andrew Lee, in an extensive review of Libertys current business and market position, points out the Swiss acquisition as a key factor for the companys future. He writes, We view Sunrise as a quality asset, with sustained market share growth potential. We expect this to benefit LBTYA directly as Sunrise continues to win share from Swisscom but also to help stabilize the UPC asset.Lee gives LBTYA shares a Buy rating along with a $33 price target. This figure implies ~36% one-year upside from current levels. (To watch Lees track record, click here)Like RIDE above, Liberty has an even split among its recent reviews in this case, 3 Buys and 2 Holds, making the analyst consensus view a Moderate Buy. The shares are priced at $24.32, and the average price target of $30.12 indicates room for ~24% growth from that level. (See LBTYA stock analysis on TipRanks)Lufax Holding (LU)Fintech is a rapidly growing niche, and Lufax operates a personal financial services platform serving the Chinese market. The company provides wealth management for the fast-growing middle class in China, a population that is not only growing in size but also in affluence. Lufax offers financing solutions for personal and business loans to this population, which is not always well-served by Chinas established banking sector. The companys customer base includes small business owners and salaried workers.Revenue for the third quarter, reported earlier this month, came in at $2 billion in US currency. The EPS of 24 cents beat the estimates by 10 cents, or 71%. These numbers were down year-over-year, however.The key uncertainty facing Lufax at the present is state regulation. Chinas government, while permitting a market-based economy, keeps a tight grip on economic activity generally, and modern, cutting edge companies like Lufax can run afoul of regulators who are sometimes uncomfortable with the digital world. The prospect of tighter regulation, as government officials seek to impose controls on fintech, has some investors worried.After an extensive review of the Chinese tech regulatory environment, Goldmans Elsie Cheng, who covers Lufax, noted: We remain constructive on Lufaxs capability to navigate through the continually evolving regulatory environment and deliver consistent value-add to its consumers/financial partners.In light of that, Cheng rates LU a Buy alongside a $20 price target, which implies a 34% upside for the year ahead. (To watch Chengs track record, click here)All in all, the Moderate Buy analyst consensus rating on Lufax is based on 7 reviews, including 4 Buys and 3 Holds. The average price target of $17.70 indicates a potential 15% upside next year. (See LU stock analysis on TipRanks)To find good ideas for stocks trading at attractive valuations, visit TipRanks Best Stocks to Buy, a newly launched tool that unites all of TipRanks equity insights.Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment.

Europe Stocks Climb With U.S. Futures; Dollar Dips: Markets Wrap

Otis Worldwide is among the top dividend stocks due to its strong cash generation potential. Its free cash flow conversion ratio is likely to stand at 135% of net income in the December quarter. The company currently offers a quarterly dividend of $0.20 per share, yielding above 1%.

Otis is a perfect pick for value investors because it offers robust share price growth along with hefty dividends. Its stock price soared almost 40% since the beginning of fiscal 2020, thanks to the substantial improvement in profits. The adjusted diluted earnings per share of elevators and escalators manufacturers rose 25.5% year over year to $0.69 in the latest quarter.

Every week, Benzinga conducts a sentiment survey to find out what traders are most excited about, interested in or thinking about as they manage and build their personal portfolios.We surveyed a group of over 200 investors on whether shares of Palantir (NYSE: PLTR) will reach $50 by 2022.Palantir Stock Forecast Palantir delivers big data analytics software solutions to United States government projects. Palantir released its Gotham software platform in 2008, which is the platform that primarily focuses on providing data analytics solutions to the U.S. governments intelligence and defense sectors.The company also provides non-government organizations with solutions to manage large disparate data sets in an attempt to gain insight and drive operational outcomes.Palantirs stock debuted Sept. 30 at $10 a share and trades around $28 at time of publishing; 78% of Benzinga investors said Palantir would reach $50 per share by the end of 2022.Traders and investors who participated in our study said Palantirs stock will increase off new and continuing partnerships with the U.S. government and defense-related projects. Although Palantir has yet to turn a financial profit in its 17-year history, Benzinga readers see Palantir leadership, including co-founder and CEO Alex Karp, accelerating revenue growth in the near-term.See Also: Top 10 Blue Chip Stocks.This survey was conducted by Benzinga in December 2020 and included the responses of a diverse population of adults 18 or older.Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from over 200 adults.Photo courtesy: Cory Doctorow via FlickrSee more from Benzinga * Click here for options trades from Benzinga * Thinking About Buying Stock In Palantir, FuboTV, Apple, Shopify Or Snowflake? * Thinking About Buying Stock In Palantir, Nio, Carnival, Plug Power Or Moderna?(C) 2020 . Benzinga does not provide investment advice. All rights reserved.

His investment strategy is clearly reflecting from the stock picks in the latest quarter as the Soros Fund Management has either eliminated or reduced its positions in banks and financial services companies. The banking and financial sector is likely to face hard times amid low-interest rates and consumers shift towards digital platforms for payment transactions.

NortonLifeLock is founded in 2018 after Broadcom (NASDAQ:AVGO) bought Symantecs enterprise security assets for $10.7 billion. The company currently offers a quarterly dividend of $0.125 per share, yielding above 2.50%.

Every week, Benzinga conducts a sentiment survey to find out what traders are most excited about, interested in or thinking about as they manage and build their personal portfolios.We surveyed a group of over 300 investors on whether shares of FuelCell (NASDAQ: FCEL) will reach $20 by 2022.FuelCell Stock Forecast FuelCell Energy designs manufactures,